SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

bioAffinity Technologies, Inc.
Date: April 16, 2025 · CIK: 0001712762 · Accession: 0000000000-25-004016

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-286497

Date
April 16, 2025
Author
Division of
Form
UPLOAD
Company
bioAffinity Technologies, Inc.

Letter

Re: bioAffinity Technologies, Inc. Registration Statement on Form S-1 Filed April 11, 2025 File No. 333-286497 Dear Maria Zannes:

April 16, 2025

Maria Zannes Chief Executive Officer bioAffinity Technologies, Inc. 3300 Nacogdoches Road San Antonio, TX 78217

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Margaret Sawicki at 202-551-7153 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Leslie Marlow, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 April 16, 2025

Maria Zannes
Chief Executive Officer
bioAffinity Technologies, Inc.
3300 Nacogdoches Road
San Antonio, TX 78217

 Re: bioAffinity Technologies, Inc.
 Registration Statement on Form S-1
 Filed April 11, 2025
 File No. 333-286497
Dear Maria Zannes:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Margaret Sawicki at 202-551-7153 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Industrial
Applications and
 Services
cc: Leslie Marlow, Esq.
</TEXT>
</DOCUMENT>